MAT-2304770 v1.0
The Amplatzer portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The closure procedures are performed through a transcatheter approach, which prevents the need for open heart surgery and enables faster recovery times.
The Amplatzer™ Talisman™ PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke. It’s the leading PFO closure device to date, with over 180,000 devices implanted worldwide.1
The Amplatzer™ Amulet™ Left Atrial Appendage Occluder is the only FDA-approved LAA occluder that offers immediate freedom from OACs. With unique dual seal technology to ensure immediate and complete closure and the widest range of sizes of any LAA occluder, Amulet™ makes closure an option for more AFib patients.2
MAT-2304770 v1.0
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
MAT-2408064 V1.0